Index of medicine substances

Fluticasone furoate  •  Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids (R01AD12)

Fluticasone furoate + umeclidinium + vilanterol  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL08)

Fluticasone propionate  •  Respiratory system | Other drugs for obstructive airway diseases, inhalants | Glucocorticoids (R03BA05)

Fluticasone + formoterol  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics (R03AK11)

Fluticasone + vilanterol  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics (R03AK10)

Flutrimazole  •  Dermatologicals | Antifungals for topical use | Imidazole and triazole derivatives (D01AC16)

Fluvastatin  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors (C10AA04)

Fluvoxamine  •  Nervous system | Antidepressants | Selective serotonin reuptake inhibitors (N06AB08)

Folic acid  •  Blood and blood forming organs | Vitamin b12 and folic acid | Folic acid and derivatives (B03BB01)

Follitropin alfa  •  Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants (G03GA05)

Follitropin alfa + lutropin alfa  •  Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants (G03GA30)

Follitropin beta  •  Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants (G03GA06)

Follitropin delta  •  Genito urinary system and sex hormones | Gonadotropins and other ovulation stimulants (G03GA10)

Fomepizole  •  Various | All other therapeutic products | All other therapeutic products | Antidotes (V03AB34)

Fondaparinux sodium  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Other antithrombotic agents (B01AX05)

Formoterol  •  Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists (R03AC13)

Formoterol + glycopyrronium + budesonide  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL11)

Fosamprenavir  •  Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors (J05AE07)

Fosaprepitant  •  Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Other antiemetics (A04ADN1)

Foscarnet  •  Antiinfectives for systemic use | Direct acting antivirals | Phosphonic acid derivatives (J05AD01)

Fosfomycin  •  Antiinfectives for systemic use | Other antibacterials (J01XX01)

Fosinopril  •  Cardiovascular system | Ace inhibitors, plain (C09AA09)

Fosinopril + hydrochlorothiazide  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics (C09BA09)

Foslevodopa + foscarbidopa  •  Nervous system | Dopaminergic agents | Dopa and dopa derivatives (N04BA07)

Fostemsavir  •  Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX29)

Fotemustine  •  Antineoplastic and immunomodulating agents | Alkylating agents | Nitrosoureas (L01AD05)

Fremanezumab  •  Nervous system | Antimigraine preparations | Calcitonin gene-related peptide (CGRP) antagonists (N02CD03)

Frovatriptan  •  Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists (N02CC07)

Fruquintinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (L01EK04)

Fulvestrant  •  Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens (L02BA03)